- Report
- September 2026
- 194 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- September 2026
- 366 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- August 2026
- 120 Pages
Global
From €4319EUR$4,750USD£3,713GBP
- Report
- August 2026
- 160 Pages
Global
From €3019EUR$3,320USD£2,595GBP
€3774EUR$4,150USD£3,244GBP
- Report
- September 2026
- 185 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- September 2026
- 194 Pages
Global
From €3224EUR$3,545USD£2,771GBP
€3582EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- February 2026
- 250 Pages
Global
From €4083EUR$4,490USD£3,510GBP
- Report
- July 2023
- 130 Pages
Global
From €5410EUR$5,950USD£4,651GBP
- Report
- February 2024
- 179 Pages
Global
From €4092EUR$4,500USD£3,518GBP
- Report
- June 2023
- 115 Pages
Global
From €4092EUR$4,500USD£3,518GBP
- Report
- February 2024
- 124 Pages
Global
From €3865EUR$4,250USD£3,322GBP
- Report
- November 2022
- 131 Pages
Africa, Middle East
From €3137EUR$3,450USD£2,697GBP
- Report
- November 2022
- 140 Pages
Asia Pacific
From €3137EUR$3,450USD£2,697GBP
- Report
- November 2022
- 128 Pages
North America
From €3137EUR$3,450USD£2,697GBP
- Report
- April 2025
Germany, Italy, Japan, ... Germany, Italy, Japan, Spain, Europe
From €6820EUR$7,500USD£5,863GBP
- Report
- April 2025
France
From €2273EUR$2,500USD£1,954GBP
- Report
- April 2025
United Kingdom
From €2273EUR$2,500USD£1,954GBP

The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings.
The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests.
Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more